Globus Medical (GMED) Net Cash Flow (QoQ) (2011 - 2026)
Globus Medical (GMED) Net Cash Flow (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn |
| 10 | Globus Medical | 10.62 Bn | 9.99 Bn | 525.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.80% |
| Dec 31, 2025 | 6.02% |
| Sep 30, 2025 | 157.60% |
| Jun 30, 2025 | 24.65% |
| Mar 31, 2025 | -296.87% |
| Dec 31, 2024 | -20.32% |
| Sep 30, 2024 | 296.03% |
| Jun 30, 2024 | 147.84% |
| Mar 31, 2024 | -158.46% |
| Dec 31, 2023 | 749.42% |
| Sep 30, 2023 | -132.78% |
| Jun 30, 2023 | 31.36% |
| Mar 31, 2023 | 293.66% |
| Dec 31, 2022 | 200.32% |
| Sep 30, 2022 | 78.38% |
| Jun 30, 2022 | -313.75% |
| Mar 31, 2022 | 121.86% |
| Dec 31, 2021 | -281.15% |
| Sep 30, 2021 | 10.81% |
| Jun 30, 2021 | 255.57% |